ACE Convergence Acquisition Corp. (NASDAQ:ACEV) announced this morning that it will issue additional shares to PIPE investors as it works towards closing its combination with electronics manufacturer Tempo Automation.
PIPE investors are to receive up to 2,000,000 additional shares on a pro rata basis according to a formula based on the combined company’s VWAP in the 30 days following its resale shelf effectiveness date. The formulas determining the number of shares each PIPE investor are complex and laid out on ACE Convergence’s profile page. But, the key benchmark in determining these amounts – the adjustment VWAP – was also revised downward from $6.50 to $4.00 in the changes.
The tweaks come as ACE Convergence is set to hold its vote to complete the transaction next week on July 12 and today is the SPAC’s redemption deadline. It initially announced the transaction with $107 million in PIPE commitments – $82 million equity and $25 million made up of convertible notes.
But it has since upsized this financing to $200 million in convertible notes supplemented by a $100 million committed equity facility, under which Tempo can direct Cantor Fitzgerald to make share purchases at the company’s discretion.
Along with the PIPE changes, the ACE Convergence’s sponsor will now subject 2,000,000 promote shares (35.7%) to earnout conditions. These are to vest 15 months out from close, or earlier if Tempo closes “a strategic transaction”. The new PIPE agreement also includes provisions for adjustment should “a strategic transaction” take place.
The parties initially announced their $935 million deal on October 14, 2021. San Francisco-based Tempo provides outsourced digital manufacturing services for electronics and other circuitry applications.
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...
NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...